However, after extensive investigations, although most of the studies have demonstrated their glioma-suppressor roles [9,10,11,12,13,14,15], accumulating data indicated that the BMPs effect on glioma development might be tumor phenotype-dependent [24]. This evidence concerns the gene CLN5 and central nervous system cancer.